Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction
Open Access
- 1 January 2012
- journal article
- review article
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 2012, 1-18
- https://doi.org/10.1100/2012/640389
Abstract
Melatonin is a highly pleiotropic signaling molecule, which is released as a hormone of the pineal gland predominantly during night. Melatonin secretion decreases during aging. Reduced melatonin levels are also observed in various diseases, such as types of dementia, some mood disorders, severe pain, cancer, and diabetes type 2. Melatonin dysfunction is frequently related to deviations in amplitudes, phasing, and coupling of circadian rhythms. Gene polymorphisms of melatonin receptors and circadian oscillator proteins bear risks for several of the diseases mentioned. A common symptom of insufficient melatonin signaling is sleep disturbances. It is necessary to distinguish between symptoms that are curable by short melatonergic actions and others that require extended actions during night. Melatonin immediate release is already effective, at moderate doses, for reducing difficulties of falling asleep or improving symptoms associated with poorly coupled circadian rhythms, including seasonal affective and bipolar disorders. For purposes of a replacement therapy based on longer-lasting melatonergic actions, melatonin prolonged release and synthetic agonists have been developed. Therapies with melatonin or synthetic melatonergic drugs have to consider that these agents do not only act on the SCN, but also on numerous organs and cells in which melatonin receptors are also expressed.Keywords
This publication has 227 references indexed in Scilit:
- Circadian rhythms and treatment implications in depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Prospective Study of Common Variants in the Retinoic Acid Receptor–Related Orphan Receptor α Gene and Risk of Neovascular Age-Related Macular DegenerationJAMA Ophthalmology, 2010
- Genome-Wide Association Scan of Trait DepressionBiological Psychiatry, 2010
- Removal of Melatonin Receptor Type 1 Induces Insulin Resistance in the MouseObesity, 2010
- Distinct Contributions of Rod, Cone, and Melanopsin Photoreceptors to Encoding IrradianceNeuron, 2010
- Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: A systems biology based approachVision Research, 2010
- A Genomewide Association Study of Citalopram Response in Major Depressive DisorderBiological Psychiatry, 2010
- Key Research Opportunities in Immune System AgingThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- DNA damage, cellular senescence and organismal ageing: causal or correlative?Nucleic Acids Research, 2007
- Circadian genes, rhythms and the biology of mood disordersPharmacology & Therapeutics, 2007